Posterior reversible encephalopathy syndrome is a clinicoradiologic entity that may present with headaches, altered mental status, seizures and visual loss as well as specific neuroimaging findings. We report a case of a 74-year-old woman receiving adjuvant gemcitabine chemotherapy as monotherapy for a stage IIa pancreatic adenocarcinoma, who developed posterior reversible encephalopathy syndrome. © 2011 S. Karger AG, Basel.
CITATION STYLE
Marrone, L. C. P., Marrone, B. F., De La Puerta Raya, J., Gadonski, G., & Da Costa, J. C. (2011). Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome. Case Reports in Oncology, 4(1), 82–87. https://doi.org/10.1159/000324581
Mendeley helps you to discover research relevant for your work.